iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 34.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,622 shares of the financial services provider’s stock after acquiring an additional 1,177 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $684,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in IBB. BNP Paribas Financial Markets grew its holdings in shares of iShares Biotechnology ETF by 25.7% in the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock worth $282,038,000 after acquiring an additional 420,053 shares during the last quarter. Global Assets Advisory LLC acquired a new position in iShares Biotechnology ETF during the first quarter valued at $66,059,000. Raymond James Financial Services Advisors Inc. lifted its position in shares of iShares Biotechnology ETF by 24.6% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after purchasing an additional 42,822 shares in the last quarter. Commonwealth Equity Services LLC increased its stake in iShares Biotechnology ETF by 5.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock valued at $27,267,000 after buying an additional 10,033 shares during the period. Finally, Raymond James & Associates lifted its position in iShares Biotechnology ETF by 4.4% in the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after buying an additional 7,931 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $145.58 on Tuesday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57. The company’s fifty day simple moving average is $145.81 and its 200-day simple moving average is $138.68.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.